{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T13:13:33Z","timestamp":1746710013734,"version":"3.40.5"},"reference-count":36,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,6,1]]},"abstract":"<jats:p>Background. A national shortage of heptavalent pneumococcal conjugate vaccine (PCV7) occurred from September 2001 through May 2003. In December 2001 and January 2002, the Advisory Committee on Immunization Practices and the American Academy of Pediatrics (AAP) issued PCV7-shortage recommendations, emphasizing that all health care providers decrease the number of doses for healthy children so that more children could receive some PCV7.<\/jats:p>\n               <jats:p>Objectives. We assessed (1) how the PCV7 shortage affected pediatricians, (2) whether children in the public and private sectors were vaccinated differently during the shortage, (3) pediatricians' knowledge of and adherence to the Advisory Committee on Immunization Practices\/AAP recommendations, (4) and what factors were associated with nonadherence to the recommendations.<\/jats:p>\n               <jats:p>Methods. We conducted a cross-sectional mail survey of 2500 US physician-members of the AAP from November 2002 through March 2003; physicians providing childhood immunizations were eligible. We asked about PCV7-shortage experience, assessed recommendation adherence through clinical scenarios, and modeled potential factors associated with reported nonadherence to the recommendation to defer the fourth PCV7 dose.<\/jats:p>\n               <jats:p>Results. Of 2478 surveys sent to valid addresses, 1412 (57%) completed surveys were received; 946 (67%) of these were from eligible pediatricians. Overall, 79% experienced a PCV7 shortage, 94% reported being aware of the recommendations, and 42% reported barriers to recommendation adherence. Ninety-four percent reported vaccinating 6-month-old infants with private or public insurance in the same manner. As recommended, 91% reported fully vaccinating high-risk patients. Contrary to recommendations, 49% reported sometimes or always administering the fourth PCV7 dose to healthy children 12 to 15 months old; their reasons included recurrent otitis media, childcare attendance, and parental desire. Controlling for other characteristics, pediatricians who had no PCV7 shortage in their practices were significantly more likely to report administering the fourth dose than pediatricians who had a shortage (odds ratio [OR]: 3.67; 95% confidence interval [CI]: 2.40\u20135.63). Other factors associated with nonadherence were being in solo private practice (OR: 2.18; 95% CI: 1.26\u20133.77) or being male (OR: 1.51; 95% CI: 1.08\u20132.12). Among pediatricians deferring PCV7, 36% reported having no system to track children for whom PCV7 was deferred.<\/jats:p>\n               <jats:p>Conclusions. Many pediatricians, both with and without a PCV7 shortage, administered more PCV7 doses than recommended. Pediatricians without a shortage were less likely to limit use, which suggests that they might have focused on the perceived value of administering the full schedule to their patients in preference to broader public health goals. Providing more information to physicians on the effectiveness of a fewer-dose schedule and the risk of disease when vaccine is deferred and educating parents might increase adherence to recommendations and achieve more equitable coverage during vaccine shortages.<\/jats:p>","DOI":"10.1542\/peds.2004-1617","type":"journal-article","created":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T17:19:46Z","timestamp":1117646386000},"page":"1479-1487","source":"Crossref","is-referenced-by-count":16,"title":["Who's Calling the Shots? Pediatricians' Adherence to the 2001\u20132003 Pneumococcal Conjugate Vaccine\u2013Shortage Recommendations"],"prefix":"10.1542","volume":"115","author":[{"given":"Karen R.","family":"Broder","sequence":"first","affiliation":[{"name":"National Immunization Program"},{"name":"Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"MacNeil","sequence":"additional","affiliation":[{"name":"National Immunization Program"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shauna","family":"Malone","sequence":"additional","affiliation":[{"name":"National Immunization Program"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Schwartz","sequence":"additional","affiliation":[{"name":"National Immunization Program"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew L.","family":"Baughman","sequence":"additional","affiliation":[{"name":"National Immunization Program"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trudy V.","family":"Murphy","sequence":"additional","affiliation":[{"name":"National Immunization Program"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry K.","family":"Pickering","sequence":"additional","affiliation":[{"name":"National Immunization Program"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John S.","family":"Moran","sequence":"additional","affiliation":[{"name":"National Immunization Program"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2005,6,1]]},"reference":[{"key":"2021120819205127300_R1","unstructured":"Centers for Disease Control and Prevention. Shortage of tetanus and diphtheria toxoids [published correction appears in MMWR Morb Mortal Wkly Rep. 2001;50:126]. MMWR Morb Mortal Wkly Rep.\u20082000;49:1029\u20131030"},{"key":"2021120819205127300_R2","unstructured":"Centers for Disease Control and Prevention. Update on the supply of tetanus and diphtheria toxoids and the diphtheria and tetanus toxoids and acellular pertussis vaccine. MMWR Morb Mortal Wkly Rep.\u20082001;50:189\u2013190"},{"key":"2021120819205127300_R3","unstructured":"Centers for Disease Control and Prevention. Decreased availability of pneumococcal conjugate vaccine. MMWR Morb Mortal Wkly Rep.\u20082001;50:783\u2013784"},{"key":"2021120819205127300_R4","unstructured":"Centers for Disease Control and Prevention. Shortage of varicella and measles, mumps and rubella vaccines and interim recommendations from the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep.\u20082002;51:190\u2013191"},{"key":"2021120819205127300_R5","unstructured":"Centers for Disease Control and Prevention. 2004 childhood and adolescent immunization schedule. Available at: www.cdc.gov\/nip\/recs\/child-schedule.htm#Printable. Accessed June 8, 2004"},{"key":"2021120819205127300_R6","unstructured":"Centers for Disease Control and Prevention. Updated recommendations on the use of pneumococcal conjugate vaccine in a setting of vaccine shortages\u2014Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep.\u20082001;50:1140\u20131142"},{"key":"2021120819205127300_R7","unstructured":"Overturf GD. New recommendations for pneumococcal conjugate vaccine in a setting of vaccine shortages. AAP News. January 2002"},{"key":"2021120819205127300_R8","unstructured":"Preboth M. Vaccine shortages and delays continue in 2002. Available at: www.findarticles.com\/cf_dls\/m3225\/8_65\/85285629\/p1\/article.jhtml. Accessed June 8, 2004"},{"key":"2021120819205127300_R9","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics.\u20082000;106:362\u2013366","DOI":"10.1542\/peds.106.2.362"},{"key":"2021120819205127300_R10","unstructured":"Centers for Disease Control and Prevention. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep.\u20082000;49(RR-9):1\u201338"},{"key":"2021120819205127300_R11","unstructured":"Centers for Disease Control and Prevention. Pneumococcal conjugate vaccine shortage resolved. MMWR.\u20082003;52:446\u2013447"},{"key":"2021120819205127300_R12","unstructured":"American Academy of Pediatrics. Demographic characteristics. Available at: www.aap.org\/womenpeds\/demographics2003.doc. Accessed June 7, 2004"},{"key":"2021120819205127300_R13","unstructured":"Centers for Disease Control and Prevention. Vaccines for Children program. Available at: www.cdc.gov\/nip\/vfc. Accessed May 5, 2004"},{"key":"2021120819205127300_R14","doi-asserted-by":"crossref","unstructured":"Freed GL, Davis MM, Clark JS. Variation in public and private supply of pneumococcal conjugate vaccine during a shortage. JAMA.\u20082003;289:575\u2013578","DOI":"10.1001\/jama.289.5.575"},{"key":"2021120819205127300_R15","doi-asserted-by":"crossref","unstructured":"Stokely S., Santoli JM, Bayo W, Vanda K, Vargas-Rosales A, Rodewald LE. Impact of vaccine shortages on immunization programs and providers. Am J Prev Med.\u20082004;26:15\u201321","DOI":"10.1016\/j.amepre.2003.09.010"},{"key":"2021120819205127300_R16","doi-asserted-by":"crossref","unstructured":"Zun LS, Downey L. Tetanus immunization shortage in the United States. Am J Emerg Med.\u20082003;21:298\u2013301","DOI":"10.1016\/S0735-6757(03)00086-X"},{"key":"2021120819205127300_R17","doi-asserted-by":"crossref","unstructured":"Mary RC, Abrahmse AF, Hirsch SH, Frank JC, Reuben DB. What influences physician practice behavior? An interview study of physicians who received consultative geriatric assessment recommendations. Arch Fam Med.\u20081996;5:448\u2013454","DOI":"10.1001\/archfami.5.8.448"},{"key":"2021120819205127300_R18","unstructured":"Ely JW, Goerdt CJ, Bergus GR, West CP, Dawson JD, Doebbeling BN. The effect of physician characteristics on compliance with adult preventive care guidelines. Fam Med.\u20081998;30:34\u201339"},{"key":"2021120819205127300_R19","unstructured":"Costanza ME, Stoddard AM, Zapka JG, Gaw VP, Barth R. Physician compliance with mammography guidelines: barriers and enhancers. J Am Board Fam Pract.\u20081992;5:143\u2013152"},{"key":"2021120819205127300_R20","doi-asserted-by":"crossref","unstructured":"Davis MM, Ndiaye SM, Freed GL, Clark SJ. One-year uptake of pneumococcal conjugate vaccine: a national survey of family physicians and pediatricians. J Am Board Fam Pract.\u20082003;16:363\u2013371","DOI":"10.3122\/jabfm.16.5.363"},{"key":"2021120819205127300_R21","doi-asserted-by":"crossref","unstructured":"Winkler JD, Lohr KN, Brook RH. Persuasive communication and medical technology assessment. Arch Intern Med.\u20081985;145:314\u2013317","DOI":"10.1001\/archinte.145.2.314"},{"key":"2021120819205127300_R22","unstructured":"Beaulieu MD, Hudon E, Roberge D, Pineault R, Forte D, Legare J. Practice guidelines for clinical prevention: do patients, physicians and experts share common ground?CMAJ.\u20081999;161:519\u2013523"},{"key":"2021120819205127300_R23","unstructured":"Centers for Disease Control and Prevention. Updated recommendations on the use of pneumococcal conjugate vaccine: suspension of recommendation for third and fourth dose. MMWR Morb Mortal Wkly Rep.\u20082004;53:177"},{"key":"2021120819205127300_R24","doi-asserted-by":"crossref","unstructured":"Szilagyi PG, Bordley C, Vann JC, et al. Effect of patient reminder\/recall interventions on immunization rates: a review. JAMA.\u20082000;284:1820\u20131827","DOI":"10.1001\/jama.284.14.1820"},{"key":"2021120819205127300_R25","unstructured":"Centers for Disease Control and Prevention. Vaccine-preventable diseases: improving vaccination coverage in children, adolescents, and adults. A report on recommendations from the Task Force on Community Preventive Services. MMWR Recomm Rep.\u20081999;48(RR-8):1\u201315"},{"key":"2021120819205127300_R26","doi-asserted-by":"crossref","unstructured":"Tierney CD, Yusuf H, McMahon SR, et al. Adoption of reminder and recall messages for immunizations by pediatricians and public health clinics. Pediatrics.\u20082003;112:1076\u20131082","DOI":"10.1542\/peds.112.5.1076"},{"key":"2021120819205127300_R27","doi-asserted-by":"crossref","unstructured":"Asch DA, Jedrziewski MK, Christakis NA. Response rates to mail surveys published in medical journals. J Clin Epidemiol.\u20081997;50:1129\u20131136","DOI":"10.1016\/S0895-4356(97)00126-1"},{"key":"2021120819205127300_R28","unstructured":"Cummings SM, Savitz LA, Konrad TR. Reported response rates to mailed physician questionnaires. Health Serv Res.\u20082001;35:1347\u20131355"},{"key":"2021120819205127300_R29","doi-asserted-by":"crossref","unstructured":"McPhillips HA, Davis RL, Marcuse EK, Taylor JA. The rotavirus vac-cine's withdrawal and physician's trust in vaccine safety mechanisms. Arch Pediatr Adolesc Med.\u20082001;155:1051\u20131056","DOI":"10.1001\/archpedi.155.9.1051"},{"key":"2021120819205127300_R30","doi-asserted-by":"crossref","unstructured":"Davis MM, Ndiaye SM, Freed GL, Kim CS, Clark SJ. Influence of insurance status and vaccine cost on physicians' administration of pneumococcal conjugate vaccine. Pediatrics.\u20082003;112:521\u2013526","DOI":"10.1542\/peds.112.3.521"},{"key":"2021120819205127300_R31","unstructured":"United States General Accounting Office, Report to congressional requesters. Childhood vaccines: ensuring an adequate supply poses continuing challenges. Available at: www.gao.gov\/new.items\/d02987.pdf. Accessed June 8, 2004"},{"key":"2021120819205127300_R32","doi-asserted-by":"crossref","unstructured":"Santoli JM, Peter G, Arvin AM, et al. Strengthening the supply of routinely recommended vaccines in the United States: recommendations from the National Vaccine Advisory Committee. JAMA.\u20082003;290:3122\u20133128","DOI":"10.1001\/jama.290.23.3122"},{"key":"2021120819205127300_R33","unstructured":"Centers for Disease Control and Prevention. Limited supply of pneu-mococcal conjugate vaccine: suspension of recommendation for fourth dose. MMWR Morb Mortal Wkly Rep.\u20082004;53:108\u2013109"},{"key":"2021120819205127300_R34","unstructured":"Centers for Disease Control and Prevention. Why your child may have to wait to get his or her third or fourth dose of Prevnar vaccine: facts for parents. Available at: www.cdc.gov\/nip\/news\/shortages\/pcv7_parent_3-1-04.pdf. Accessed May 11, 2004"},{"key":"2021120819205127300_R35","unstructured":"Centers for Disease Control and Prevention. Limited supply of pneumococcal conjugate vaccine. MMWR Morb Mortal Wkly Rep.\u20082003;52:1234"},{"key":"2021120819205127300_R36","unstructured":"Centers for Disease Control and Prevention. Pneumococcal conjugate vaccine shortage resolved. MMWR Morb Mortal Wkly Rep.\u20082004;53:851\u2013852"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/115\/6\/1479\/1027755\/zpe00605001479.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/115\/6\/1479\/1027755\/zpe00605001479.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T20:15:18Z","timestamp":1638994518000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/115\/6\/1479\/67419\/Who-s-Calling-the-Shots-Pediatricians-Adherence-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,1]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2005,6,1]]},"published-print":{"date-parts":[[2005,6,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2004-1617","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"type":"print","value":"0031-4005"},{"type":"electronic","value":"1098-4275"}],"subject":[],"published":{"date-parts":[[2005,6,1]]}}}